Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-10
2007-07-10
Romeo, David S. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
10465474
ABSTRACT:
Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be produced recombinantly from transformed host cells with the subject nucleic acids. Also provided are isolated hybridization probes and primers capable of specifically hybridizing with the disclosed genes, specific binding agents and methods of making and using the subject compositions.
REFERENCES:
patent: 6133232 (2000-10-01), De Robertis et al.
U.S. Appl. No. 60/020,150.
Bowie et al. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science, (Mar. 16, 1990) 247 (4948) 1306-10.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, Merz and Le Grand (Eds), Aug. 1994, Springer Verlag, pp. 433 and 492-495.
Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev. Jun. 1992;32(2):160-7.
Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. Jan. 1994;8(2):133-46.
DATABASE EMBL—EMEST13, Entry MMAA20122, ACC. No. AA120122, issued Nov. 21, 1996, Marra, M. et al., “mn32d09.r1 Beddington mouse embryonic region Mus musculus cDNA clone 538769 5'”, XP-002072013.
Mechanisms of Development, vol. 68, issued Nov. 1997, “Cerberus-likeis a secreted factor with neutralizing activity expressed in the anterior primitive endoderm of the mouse gastrula”, pp. 45-57.
Developmental Biology, vol. 194, issued Feb. 15, 1998, Biben, C., et al., “Murine Cerberus Homologue mCer-1: A Candidate Anterior Patterning Molecule”, pp. 121-132.
NATURE, vol. 382, issued Aug. 15, 1996, Bouwmeester, T., et al., “Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer”, pp. 547-549.
ONCOGENE, vol. 9, issued 1994, Enomoto, H., et al., “Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus”, pp. 2785-2791.
DEVELOPMENT, vol. 124, issued 1997, Furuta, Y., et al., “Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development”, pp. 2203-2212.
CELL, vol. 77, issued Apr. 22, 1994, Hemmati-Brivanlou, A., et al., “Follistatin, an Antagonist of Activin Is Expresses in the Spemann Organizer and Displays Direct Neutralizing Activity”, pp. 283-295.
SCIENCE, vol. 262, issued Oct. 29, 1993, Lamb, T.M., et al., “Neural Induction by the Secreted Polypeptide Noggin”, pp. 713-718.
Trends in Genetics, vol. 12, No. 12, issued Dec. 1996, Lemaire, P., et al., “The vertebrate organizer: structure and molecules”, pp. 525-531.
CELL, vol. 81, issued Apr. 7, 1995, Lemaire, P., et al., “Expression Cloning ofSiamois, a Xenopus Homeobox Gene Expressed in Dorsal-Vegetal Cells of Blastulae and Able to Induce A Complete Secondary Axis” pp. 85-94.
Jpn. J. Cancer Research, vol. 87, issued Jan. 1996, Ozaki, T., et al., “Cloning of MouseDANcDNA and Its Down-regulation in Transformed Cells”.
CELL, vol. 86, issued Aug. 23, 1996, Piccolo, S., et al., “Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4”, pp. 829-840.
Nature, vol. 376, issued Jul. 27, 1995, Sasai, Y., et al., “Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus”, pp. 333-336.
CELL, vol. 79, issued Dec. 2, 1994, Sasai, Y., et al., “Xenopuschordin:: A Novel Dorsalizing Factor Activated by Organizer-Specific Homeobox Genes”, pp. 779-790.
NATURE, vol. 361, issued Feb. 11, 1993, Smith, W.C., et al., “Secretednogginprotein mimics the Spemann organizer in dorsalizingXenopusmesoderm”, pp. 547-549.
CELL, vol. 67, issued Nov. 15, 1991, Smith, W.C., and Harland, R.M., “Injected Xwnt-8 RNA Acts Early in Xenopus Embryos to Promotes Formation of a Vegetal Dorsalizing Center”, pp. 752-765.
CELL, vol. 70, issued Sep. 4, 1992, Smith, W.C., and Harland, R.M., “Expression Cloning of noggin, a New Dorsalizing Factor Localized to the Spemann Organizer in Xenopus Embryos”, pp. 829-840.
CELL, vol. 86, issued Aug. 23, 1996, Zimmerman, L.B., et al., “The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4”, pp. 599-606.
Economides Aris N.
Rojas Eduardo A.
Stahl Neil
Valenzuela David M.
Gregg, Esq. Valeta
Regeneron Pharmaceuticals Inc.
Romeo David S.
LandOfFree
Morphogenic protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morphogenic protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morphogenic protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3744772